Yichen Cao

6.5k citations
16 papers · 1.7k · 1 hit paper · h-index 9

Impact in

  • Hepatology top 2%
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Liver physiology and pathology
    • Cancer, Hypoxia, and Metabolism

Papers in

Yichen Cao

15 papers receiving 1.7k citations

Yichen Cao's Hit Papers

Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5 2006 · 1.3k citations
1.3k0+6+13Years since publication4008001.2k

Peers

Yichen Cao
Comparison fields: 5 of 92
  • Hepatology 370
  • Cancer Research 294
  • Pathology and Forensic Medicine 249
  • Oncology 329
  • Pulmonary and Respiratory Medicine 300
Replace Anna Saborowski with:
Anna Saborowski Germany
Lila Adnane United States
Miriam Farina Italy
Wei‐Tien Tai Taiwan
Dean Wilkie United States
Dana T. Aftab United States
Zong‐Tao Chai China
Bazarragchaa Damdinsuren Japan
Robert Montal Spain
Francesco Dituri Italy
Yichen Cao relative to Anna Saborowski Germany Anna Saborowski's profile →
Citations per field
00.5×1.5×2.5×
Anna Saborowski · 1×
Citations per year

Countries citing papers authored by Yichen Cao

Since Specialization
Citations

This map shows the geographic impact of Yichen Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yichen Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yichen Cao more than expected).

Fields of papers citing papers by Yichen Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yichen Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yichen Cao. The network helps show where Yichen Cao may publish in the future.

Co-authors

The 25 scholars most cited alongside Yichen Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yichen Cao Line = papers co-authored together Yichen Cao links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1
Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5
Hit paper breakdown →
20061307
2 1999152
3 199686
4 199948
5 201735
6 201733
7 200019
8 202219
9 199913
10 20118
11 20198
12 20123
13 20242
14 20131
15 19961
16 20220

About Yichen Cao

Yichen Cao is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 16 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Molecular Biology Techniques and Applications (2 papers), Prostate Cancer Treatment and Research (2 papers), Galectins and Cancer Biology (1 paper), Corneal Surgery and Treatments (1 paper), Fuel Cells and Related Materials (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Hepatology (370 citations), Cancer Research (294 citations), Pathology and Forensic Medicine (249 citations), Oncology (329 citations) and Pulmonary and Respiratory Medicine (300 citations). Yichen Cao has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Xiaomei Zhang, Dean Wilkie, Charles Chen, Scott M. Wilhelm, Mark Lynch, Li Liu, Christopher Carter, Ralph Buttyan, Alexandre de la Taille and Martin Burchardt. Their work appears in journals such as The Journal of Urology, Cancer Research, Molecular Therapy, Blood and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact